Jaguar Health, Inc. Note Agreements

27 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
NOTE PURCHASE AGREEMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Note Purchase Agreement, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Secured Promissory Note, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Promissory Note, dated October 1, 2019, between Napo Pharmaceuticals, Inc. and Michael Tempesta
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Form of 125% Coverage Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Form of 75% Coverage Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Note Purchase Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Note Purchase Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Secured Promissory Note, dated March 21, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Secured Promissory Note, dated February 26, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Second Amendment to the Note Purchase Agreement and Notes and Payoff Agreement, dated February 16, 2018, by and among Jaguar Health, Inc. and the purchasers named therein
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Form of Second Amended Original Issue Discount Exchangeable Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
First Amendment to the Note Purchase Agreement and Notes, dated December 29, 2017, by and among Jaguar Health, Inc. and the purchasers named therein
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Form of First Amended Original Issue Discount Exchangeable Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Secured Promissory Note, dated December 8, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
SECURED CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
FORM OF CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
AMENDED AND RESTATED NOTE PURCHASE AGREEMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
FORM OF EXCHANGEABLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
JAGUAR ANIMAL HEALTH, INC. CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
FORM OF JAGUAR ANIMAL HEALTH, INC. NOTE EXERCISE AMENDMENT AND CONVERSION AGREEMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
FORM OF JAGUAR ANIMAL HEALTH, INC. JUNE/2014 CONVERTIBLE NOTE EXERCISE AMENDMENT
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
JAGUAR ANIMAL HEALTH, INC. FORM OF CONVERTIBLE PROMISSORY NOTE
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015